Cellectar Biosciences, Inc. - COM NEW (CLRB)

Historical Portfolio Holders from Q2 2022 to Q3 2024

All holders as of September 30, 2024
Q3 2024
Type / Class
Equity / COM NEW
Shares, excl. options Q3 2024
14M
Holdings value Q3 2024
$30M
Value change Q3 2024
+$5.03M
Grand Portfolio weight change Q3 2024
+0%
Number of holders
34
Number of buys Q3 2024
13
Number of sells Q3 2024
-17
Average buys Q3 2024 %
+0%
Average sells Q3 2024 %
0%
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors
Period Shares, Excl. Options Value, Excl. Options Change Price Investors
2024 Q3 14M $30M +$5.03M $2.14 34
2024 Q2 11.6M $28.3M +$5.52M $2.50 37
2024 Q1 9.13M $36.3M +$2.84M $3.98 45
2023 Q4 8.58M $23.8M +$10.4M $2.77 25
2023 Q3 1.46M $3.85M -$265K $2.64 20
2023 Q2 1.58M $3.08M -$218K $1.95 19
2023 Q1 1.69M $2.43M -$324K $1.43 18
2022 Q4 1.88M $3.22M +$2.15M $1.71 23
2022 Q3 636K $2.14M +$2.12M $3.36 18
2022 Q2 56K $23K +$23K $0.41 1